Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.2600 (3.24%) ($4.9500 - $5.3900) on Fri. Aug. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.35% (three month average) | RSI | 43 | Latest Price | $5.2600(3.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -6.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TLT(31%) VIXM(15%) TIP(35%) VCIT(33%) GLD(12%) | Factors Impacting CAPR price | CAPR will decline at least -4.175% in a week (0% probabilities). URA(-37%) XLB(-34%) PAVE(-28%) XOP(-24%) OIH(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.175% (StdDev 8.35%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-21.5(-508.75%) | Resistance Level | $6.35 | 5 Day Moving Average | $5.43(-3.13%) | 10 Day Moving Average | $5.82(-9.62%) | 20 Day Moving Average | $6.35(-17.17%) | To recent high | -46.4% | To recent low | 5% | Market Cap | $104m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |